XML 47 R35.htm IDEA: XBRL DOCUMENT v3.25.3
Stock-Based Compensation and Stock Repurchase Program (Tables)
6 Months Ended
Sep. 30, 2025
Equity [Abstract]  
Schedule Of Share-Based Payment Award, Restricted Stock Purchase Plan, Valuation Assumptions
The assumptions used in the Black-Scholes valuation model to estimate the value of our ESPP purchase rights were as follows:
 Three Months Ended
September 30,
20252024
Risk-free interest rate
3.9 - 4.1%
4.5 - 5.0%
Expected volatility
27 - 29%
21 - 22%
Weighted-average volatility28 %21 %
Expected term
6 - 12 months
6 - 12 months
Expected dividends0.7 %0.6 %
Disclosure Of Stock-Based Compensation Arrangements By Stock-Based Payment Award
The following table summarizes our stock option activity for the six months ended September 30, 2025:
Options
(in thousands)
Weighted-
Average
Exercise Prices
Weighted-
Average
Remaining
Contractual
Term  (in years)
Aggregate
Intrinsic Value
(in millions)
Outstanding as of March 31, 2025
$63.51 
Granted148.40 
Exercised(4)93.09 
Forfeited, cancelled or expired— — 
Outstanding as of September 30, 2025
$56.16 2.64$0.5 
Vested and expected to vest$56.16 2.64$0.5 
Exercisable as of September 30, 2025
$56.16 2.64$0.5 
The following table summarizes our restricted stock units activity for the six months ended September 30, 2025:
Restricted
Stock Units
(in thousands)
Weighted-
Average Grant
Date Fair Values
Outstanding as of March 31, 2025
7,549 $133.90 
Granted3,579 150.47 
Vested(2,754)133.16 
Forfeited or cancelled(347)137.34 
Outstanding as of September 30, 2025
8,027 $141.39 
The following table summarizes our performance-based restricted stock unit activity, presented with the maximum number of shares that could potentially vest, for the six months ended September 30, 2025:
Performance-
Based Restricted
Stock Units
(in thousands)
Weighted-
Average Grant
Date Fair Value
Outstanding as of March 31, 2025
1,004 $134.60 
Granted813 151.10 
Vested(266)150.23 
Forfeited or cancelled(451)136.91 
Outstanding as of September 30, 2025
1,100 $142.08 
The following table summarizes our market-based restricted stock unit activity, presented with the maximum number of shares that could potentially vest, for the six months ended September 30, 2025:
Market-Based
Restricted  Stock
Units
(in thousands)
Weighted-
Average  Grant
Date Fair Value
Outstanding as of March 31, 2025
637 $115.43 
Granted367 103.73 
Vested(34)150.48 
Forfeited or cancelled(80)176.70 
Outstanding as of September 30, 2025
890 $103.80 
The following table summarizes stock-based compensation expense resulting from stock options, restricted stock units, market-based restricted stock units, performance-based restricted stock units, and the ESPP purchase rights included in our Condensed Consolidated Statements of Operations (in millions):
 Three Months Ended
September 30,
Six Months Ended
September 30,
 2025202420252024
Cost of revenue$$$$
Research and development123 122 233 223 
Marketing and sales15 16 27 28 
General and administrative33 32 60 58 
Stock-based compensation expense$174 $174 $326 $317 
Schedule of Repurchase Agreements
The following table summarizes total shares repurchased during the three and six months ended September 30, 2025 and 2024:
August 2022 ProgramMay 2024 ProgramTotal
(In millions)Shares
Amount(a)
Shares
Amount(a)
SharesAmount
Three months ended September 30, 2025
— $— 2.3 $375 2.3 $375 
Six months ended September 30, 2025
— $— 5.3 $750 5.3 $750 
Three months ended September 30, 2024
— $— 2.6 $375 2.6 $375 
Six months ended September 30, 2024
1.2 $152 4.2 $598 5.4 $750 
(a)Amount excludes excise taxes. Accrued excise taxes are included in accounts payable, accrued, and other current liabilities and additional paid-in capital on the Condensed Consolidated Balance Sheets.